Application

18960021 · NEW CRYSTALLINE FORMS OF SALT OF 7-CYCLOPENTYL-2-(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE -6-CARBOXYLIC ACID DIMETHYLAMIDE

Filed 2024-11-26 · Pending The official file ↗ · Art unit 1627 · Examiner Dawanna Shar-Day White Typical · CPC A61K 31/519 · Novartis AG · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

22.0 mo

to disposition n/a

Statutes raised

103 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.